IM8 Welcomes Giannis Antetokounmpo As Minority Equity Investor With $100 Million ARR
IM8, a rapidly growing supplement brand founded in late 2024 by Prenetics (NASDAQ: PRE) and David Beckham, has welcomed legendary NBA star Giannis Antetokounmpo as a minority equity investor. The company, known for it…
By TradedVC Editorial1 min read
IM8, a rapidly growing supplement brand founded in late 2024 by Prenetics (NASDAQ: PRE) and David Beckham, has welcomed legendary NBA star Giannis Antetokounmpo as a minority equity investor. The company, known for its clinically-dosed longevity products backed by a world-class Scientific Advisory Board, reached $100 million in ARR within 11 months and anticipates over $180 million in revenue in 2026, joining other athlete investors including Aryna Sabalenka, Ollie Bearman, and Beckham.
HQ: Charlotte, North Carolina
#VentureCapital #IM8 #GiannisAntetokounmpo #DavidBeckham #TradedVC
ABOUT THE DEAL
- Raise
- $100M
- Round
- Not stated
- Company
- IM8 Welcomes Giannis Antetokounmpo As Minority Equity Investor With $100 Million ARR
- Desk
- Deals
- Filed
- Apr 3, 2026 · 2:49 PM
More deals
ALL DEALSDeal
Jakob Diepenbrock Backs 12 Companies Rebuilding American Industry With Investments From A16z And Lux Capital
Sep 29, 2026 · 6:27 PM
Deal
Akamai Technologies Secures $11.6 Billion Deal With Anthropic For Cloud Infrastructure
Sep 29, 2026 · 5:07 PM
Deal
Valley National Bank Acquires Fintech Bluevine For $340 Million
Sep 29, 2026 · 4:13 PM